Nociceptin/orphanin FQ suppresses adaptive immune responses in vivo and at picomolar levels in vitro.

Nociceptin/orphanin FQ (N/OFQ), added in vitro to murine spleen cells in the picomolar range, suppressed antibody formation to sheep red blood cells in a primary and a secondary plaque-forming cell assay. The activity of the peptide was maximal at 10(-12) M, with an asymmetric U-shaped dose-response curve that extended activity to 10(-14) M. Suppression was not blocked by pretreatment with naloxone. Specificity of the suppressive response was shown using affinity-purified rabbit antibodies against two N/OFQ peptides and with a pharmacological antagonist. Antisera against both peptides were active, in a dose-related manner, in neutralizing N/OFQ-mediated immunosuppression, when the peptide was used at concentrations from 10(-12.3) to 10(-11.6) M. In addition, nociceptin given in vivo by osmotic pump for 48 h suppressed the capacity of spleen cells placed ex vivo to make an anti-sheep red blood cell response. These studies show that nociceptin directly inhibits an adaptive immune response, i.e., antibody formation, both in vitro and in vivo.

Endomorphin 1 and endomorphin 2 suppress in vitro antibody formation at ultra-low concentrations: anti-peptide antibodies but not opioid antagonists block the activity.

Endomorphin 1 (EM-1) and endomorphin 2 (EM-2) were tested for their capacity to alter immune function. Addition of either of these peptides to murine spleen cells in vitro inhibited antibody formation to sheep red blood cells in a bi-phasic dose dependent manner. Maximal inhibition was achieved at doses in the range of 10(-13) to 10(-15)M. Neither naloxone (general opioid receptor antagonist) nor CTAP (selective mu opioid receptor antagonist) blocked the immunosuppressive effect. To show that there was specificity to the immunosuppressive activity of the peptides, affinity-purified rabbit antibodies were raised against each of the synthetic EM peptides haptenized to KLH and tested for capacity to inhibit immunosuppression. Antibody responses were monitored by a standard solid phase antibody capture ELISA, and antibodies were purified by immunochromatography using the synthetic peptides coupled to a Sepharose 6B resin. Verification of the specificity of affinity-purified antisera was performed by immunodot-blot and solid-phase RIA assays. The antisera specific for both EM-1 and EM-2 neutralized the immunosuppressive effects of their respective peptides in a dose-related manner. Control normal rabbit IgG had no blocking activity on either EM-1 or EM-2. These studies show that the endomorphins are immunomodulatory at ultra-low concentrations, but the data do not support a mechanism involving the mu-opioid receptor.

[Pathogenic characterization and study of the mycelial groups of compatibility in Sclerotium cepivorum Berk]. / Caracterización patogénica y estudio de los grupos de compatibilidad micelial en Sclerotium cepivorum Berk.

We have studied the pathogenicity and the formation of mycelial compatibility groups of (MCG) in 12 isolates of the fungus Sclerotium cepivorum Berk from the states of Táchira, Mérida, Trujillo in Venezuela and Pamplona in Colombia. The pathogenicity was evaluated according to severity and virulence. In vitro confrontation tests were used to check the presence of compatible and incompatible interactions expressed by MCG when different isolates of the fungus were put together in a petri dish. When pathogenicity was evaluated, we found high levels of disease with isolates T-9, C-1 and TR-10. The isolate T-9 was the most virulent and agressive, as the symptoms began at day 12 and at day 19 and 100% of the nine inoculated plants died. Three responses were observed when confronting S. cepivorum isolates: a reaction of compatibility or anastomosis and two reactions of incompatibility. Two MCG were found, represented by isolates T-8 (Táchira) and TR-3 (Trujillo), which showed incompatibility when faced with other isolates. These results provide a basis upon which the genetic characterization of S. cepivorum can be established.

Synaptic plasticity: understanding the neurobiological mechanisms of learning and memory: part II

Uno de los fenómenos más nteresantes dentro del campo de la neurobiología, es el fenómeno de la plasticidad cerebral relacionada con los eventos de aprendizaje y el procesamiento del fenómeno de memoria. De hecho, estos fenómenos neurobiológicos empezaron a ser estudiados desde principios de siglo. Remotamente, el fenómeno de plasticidad cerebral en relación con el desarrollo y aprendizaje de las conductas fue ya concebido y cuestionado desde hace más de dos centurias. Sin embargo, desde hace cuatro décadas, múltiples evidencias experimentales han demostrado que tanto la experiencia o el entrenamiento en la ejecución de tareas operantes aprendidas, inducen cambios plásticos en la fisiología neuronal, incluyendo los cambios neuroquímicos y moleculares que se requieren para consolidar una memoria a largo plazo. Asimismo, diversos procedimientos experimentales han demostrado que la experiencia diferencial, el entrenamiento y el aprendizaje de conductas o la experiencia informal, producen cambios mensurables en el cerebro de los mamíferos. Más aún, la neuropsicología ha considerado desde hace varias décadas que diferentes tipos de memoria pueden ser localizados en diferentes circuitos neuronales en distintas áreas de la corteza cerebral. Sin embargo, los estudios recientes han demostrado que los sistemas de memoria están distribuidos en circuitos neuronales corticales específicos. Por ejemplo, los mismos sistemas corticales que procesan la percepción sensorial y las función motora, son los mismos sustratos neurales que se emplean para procesar los fenómenos de memorización. El fenómeno de la memoria y el aprendizaje es resultado de la actividad fisiológica repetitiva de millones de neuronas que, ensambladas en circuitos neuronales específicos, conllevan al reforzamiento de las conexiones sinápticas involucradas y a los cambios de plasticidad sináptica que se requieren para establecer estos fenómenos neurobiológicos. El fenómeno de potenciación a largo plazo, o LTP, es un evento neurofisiológico que resulta del incremento en el reforzamiento de la transmisión sináptica, que puede perdurar en las regiones cerebrales estudiadas desde horas a días. El modelo de LTP quizá representa el modelo funcional experimental más viable para entender las bases celulares del aprendizaje y la memoria en el SNC de los mamíferos, incluyendo el cerebro de los humanos.